Website: https://i-base.info/
i-base.info/htb/52811
“We know what works… what we need now is political courage.”
#HIV @unaids.org #UNAIDS #EndAIDS2030 #HIVtreatment #HIVprevention #GlobalHealth
i-base.info/htb/52811
“We know what works… what we need now is political courage.”
#HIV @unaids.org #UNAIDS #EndAIDS2030 #HIVtreatment #HIVprevention #GlobalHealth
i-base.info/htb/52811
“We know what works… what we need now is political courage.”
#HIV @unaids.org #UNAIDS #EndAIDS2030 #HIVtreatment #HIVprevention #GlobalHealth
i-base.info/htb/52811
“We know what works… what we need now is political courage.”
#HIV @unaids.org #UNAIDS #EndAIDS2030 #HIVtreatment #HIVprevention #GlobalHealth
This includes asking ‘How is your sleep?’ when starting #HIVtreatment, changing ART, or every two years.
More details in our guidelines summary:
i-base.info/htb/52581
#EACS2025 #HIV #HIVsky #HIVcare #insomnia @eacsociety.bsky.social
This includes asking ‘How is your sleep?’ when starting #HIVtreatment, changing ART, or every two years.
More details in our guidelines summary:
i-base.info/htb/52581
#EACS2025 #HIV #HIVsky #HIVcare #insomnia @eacsociety.bsky.social
This includes asking ‘How is your sleep?’ when starting #HIVtreatment, changing ART, or every two years.
More details in our guidelines summary:
i-base.info/htb/52581
#EACS2025 #HIV #HIVsky #HIVcare #insomnia @eacsociety.bsky.social
This includes asking ‘How is your sleep?’ when starting #HIVtreatment, changing ART, or every two years.
More details in our guidelines summary:
i-base.info/htb/52581
#EACS2025 #HIV #HIVsky #HIVcare #insomnia @eacsociety.bsky.social
i-base.info/htb/52635
Removing the burden of daily pills for women & trans people makes #PrEPaccess more equitable & could improve low numbers in #Europe.
#EACS2025 #HIVsky
i-base.info/htb/52635
Removing the burden of daily pills for women & trans people makes #PrEPaccess more equitable & could improve low numbers in #Europe.
#EACS2025 #HIVsky
i-base.info/htb/52635
Removing the burden of daily pills for women & trans people makes #PrEPaccess more equitable & could improve low numbers in #Europe.
#EACS2025 #HIVsky
i-base.info/htb/52635
Removing the burden of daily pills for women & trans people makes #PrEPaccess more equitable & could improve low numbers in #Europe.
#EACS2025 #HIVsky
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
i-base.info/htb/52587
#HIVsky #HIVguidelines #HIVtreatment #HIVpositive #PLWH #HIVscience #Undetectable #UequalsU #InjectableART #LongActingART #abacavir #cabotegravir @bhiva.bsky.social @bashhuk.bsky.social
@ecdc.europa.eu raises threat level to moderate due to recent cases of #Clade1b in gay and bisexual men in #Europe:
i-base.info/htb/52604
People living with #HIV who are at risk of #mpox are advised to get two doses of the vaccine to be protected.
#HIVpositive #PLWH #HIVsky #IDsky
@ecdc.europa.eu raises threat level to moderate due to recent cases of #Clade1b in gay and bisexual men in #Europe:
i-base.info/htb/52604
People living with #HIV who are at risk of #mpox are advised to get two doses of the vaccine to be protected.
#HIVpositive #PLWH #HIVsky #IDsky
@ecdc.europa.eu raises threat level to moderate due to recent cases of #Clade1b in gay and bisexual men in #Europe:
i-base.info/htb/52604
People living with #HIV who are at risk of #mpox are advised to get two doses of the vaccine to be protected.
#HIVpositive #PLWH #HIVsky #IDsky
@ecdc.europa.eu raises threat level to moderate due to recent cases of #Clade1b in gay and bisexual men in #Europe:
i-base.info/htb/52604
People living with #HIV who are at risk of #mpox are advised to get two doses of the vaccine to be protected.
#HIVpositive #PLWH #HIVsky #IDsky
i-base.info/htb/52581
- #Dolutegravir dosing for newborns.
- Viral load threshold for C-section increased from >50 to >400c/mL.
- Times when formula & breastmilk #MixedFeeding is ok.
#HIV #HIVsky #breastfeeding
i-base.info/htb/52581
- #Dolutegravir dosing for newborns.
- Viral load threshold for C-section increased from >50 to >400c/mL.
- Times when formula & breastmilk #MixedFeeding is ok.
#HIV #HIVsky #breastfeeding
i-base.info/htb/52581
- #Dolutegravir dosing for newborns.
- Viral load threshold for C-section increased from >50 to >400c/mL.
- Times when formula & breastmilk #MixedFeeding is ok.
#HIV #HIVsky #breastfeeding
i-base.info/htb/52581
- #Dolutegravir dosing for newborns.
- Viral load threshold for C-section increased from >50 to >400c/mL.
- Times when formula & breastmilk #MixedFeeding is ok.
#HIV #HIVsky #breastfeeding
i-base.info/htb/52559
It highlights high rates of late diagnosis amongst migrants and calls for more support for ‘essential’ community organisations to #EndHIV.
#HIVsky @eacsociety.bsky.social
i-base.info/htb/52559
It highlights high rates of late diagnosis amongst migrants and calls for more support for ‘essential’ community organisations to #EndHIV.
#HIVsky @eacsociety.bsky.social
i-base.info/htb/52559
It highlights high rates of late diagnosis amongst migrants and calls for more support for ‘essential’ community organisations to #EndHIV.
#HIVsky @eacsociety.bsky.social
i-base.info/htb/52559
It highlights high rates of late diagnosis amongst migrants and calls for more support for ‘essential’ community organisations to #EndHIV.
#HIVsky @eacsociety.bsky.social
i-base.info/htb/52527
The two-monthly injection will protect those at high risk from #HIV and gives hope that longer-acting #lenacapavir will also be approved.
#HIVprevention #HIVsky #GUMsky @bhiva.bsky.social
i-base.info/htb/52527
The two-monthly injection will protect those at high risk from #HIV and gives hope that longer-acting #lenacapavir will also be approved.
#HIVprevention #HIVsky #GUMsky @bhiva.bsky.social
i-base.info/htb/52527
The two-monthly injection will protect those at high risk from #HIV and gives hope that longer-acting #lenacapavir will also be approved.
#HIVprevention #HIVsky #GUMsky @bhiva.bsky.social
i-base.info/htb/52527
The two-monthly injection will protect those at high risk from #HIV and gives hope that longer-acting #lenacapavir will also be approved.
#HIVprevention #HIVsky #GUMsky @bhiva.bsky.social
Our commentary and summary of the key findings:
i-base.info/htb/52473
#HIVsky #HIVtreatment #HIVprevention #HIVcare #HIVtesting #SexualHealth #PrEP #PLWH #UKHSA #STI
Our commentary and summary of the key findings:
i-base.info/htb/52473
#HIVsky #HIVtreatment #HIVprevention #HIVcare #HIVtesting #SexualHealth #PrEP #PLWH #UKHSA #STI
Our commentary and summary of the key findings:
i-base.info/htb/52473
#HIVsky #HIVtreatment #HIVprevention #HIVcare #HIVtesting #SexualHealth #PrEP #PLWH #UKHSA #STI
Our commentary and summary of the key findings:
i-base.info/htb/52473
#HIVsky #HIVtreatment #HIVprevention #HIVcare #HIVtesting #SexualHealth #PrEP #PLWH #UKHSA #STI
Read the key updates here: i-base.info/htb/52443
Send feedback to #DHHS by 9th October – details at the link.
#HIVsky #HIVtreatment #HIVguidelines #antiretrovirals #ARVs #CVD #ASCVD #semaglutide
Read the key updates here: i-base.info/htb/52443
Send feedback to #DHHS by 9th October – details at the link.
#HIVsky #HIVtreatment #HIVguidelines #antiretrovirals #ARVs #CVD #ASCVD #semaglutide
i-base.info/htb/52400
This would remove an important focus on #HIV and put #EndAIDS2030 goals in danger.
#HIVsky #GlobalHealth #UNAIDS
i-base.info/htb/52400
This would remove an important focus on #HIV and put #EndAIDS2030 goals in danger.
#HIVsky #GlobalHealth #UNAIDS
i-base.info/htb/52400
This would remove an important focus on #HIV and put #EndAIDS2030 goals in danger.
#HIVsky #GlobalHealth #UNAIDS
i-base.info/htb/52400
This would remove an important focus on #HIV and put #EndAIDS2030 goals in danger.
#HIVsky #GlobalHealth #UNAIDS
i-base.info/htb/51965
Good efficacy and safety – with a larger phase 2b study already ongoing using 200mg ULO and 2 mg ISL doses.
#HIVsky #HIVtreatment #HIVresearch
i-base.info/htb/51965
Good efficacy and safety – with a larger phase 2b study already ongoing using 200mg ULO and 2 mg ISL doses.
#HIVsky #HIVtreatment #HIVresearch
i-base.info/htb/51965
Good efficacy and safety – with a larger phase 2b study already ongoing using 200mg ULO and 2 mg ISL doses.
#HIVsky #HIVtreatment #HIVresearch
i-base.info/htb/51965
Good efficacy and safety – with a larger phase 2b study already ongoing using 200mg ULO and 2 mg ISL doses.
#HIVsky #HIVtreatment #HIVresearch
i-base.info/htb/51874
Promising early results mean that an easily-accessible #PrEPpill might even challenge six-monthly injections globally.
#HIVsky #IDsky #HIVprevention #PrEPaccess #EndAIDS2030 #Merck
i-base.info/htb/51874
Promising early results mean that an easily-accessible #PrEPpill might even challenge six-monthly injections globally.
#HIVsky #IDsky #HIVprevention #PrEPaccess #EndAIDS2030 #Merck
i-base.info/htb/51874
Promising early results mean that an easily-accessible #PrEPpill might even challenge six-monthly injections globally.
#HIVsky #IDsky #HIVprevention #PrEPaccess #EndAIDS2030 #Merck
i-base.info/htb/51874
Promising early results mean that an easily-accessible #PrEPpill might even challenge six-monthly injections globally.
#HIVsky #IDsky #HIVprevention #PrEPaccess #EndAIDS2030 #Merck